Skip to main content
Clinical Trials/CTRI/2025/06/089106
CTRI/2025/06/089106Not yet recruitingPhase 3

clinical study to evaluate the efficacy of vasa Pratisarniya kshar in the management of abhyantara arsha w.s.r internal haemorrhoid (1 st and 2nd degree)

Dr Alok Kumar yadav1 site in 1 country45 target enrollmentStarted: May 7, 2025Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
45
Locations
1
Primary Endpoint
Reduction in size of pile mass

Study Overview

Brief Summary

Arsha can be defined as dilated plexus of superior haemorrhoidal veins,in relation to

anal canal.Due to indulgence in incompatible food,there is a diminution of agni leading to constipation and vegdharana which leads to pratilomgati of Apana vayu. There are several drugs for Arshas but here I have chosen Pratisarniya kshar which not only treat it’s symptoms but also does samprapti bhanga.

Therefore I have selected 45 patients aged between 30-60 years,patients should be selected on the basis of inclusion and exclusion criteria . The trial will be of 21 days or 3 weeks follow up will be done after every week. Cured after 3rd week patient gets 80-100 percent  from sign and symptoms

Study Design

Study Type
Interventional
Allocation
Other
Masking
Not Applicable

Eligibility Criteria

Ages
30.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients having Arsha who are fulfilling my study criteria and who are willing to be selected will be enrolled Patients with 1st and 2nd degree haemorrhoids Patient of the age group above 30 years – below 60 years Patient will be selected irrespective of sex Patients who will be ready to give written consent.

Exclusion Criteria

  • Patients planning to conceive in near future[during course of trial] Any congenital diseases like haemophillia Patients with 3 degree, 4 degree or prolapsed piles Pregnant women and Lactating mothers Patients suffering from Thrombosed Piles mass,Ulcerative Colitis and CA rectum.

Outcomes

Primary Outcomes

Reduction in size of pile mass

Time Frame: 21 days or 3 week | The trial drug will be given for 3 weeks and follow up will be done after 3rd week

Secondary Outcomes

  • Bleeding reduced per rectum and relief in burning sensation(After analysing all the parameters the result will be assessed on the basis of symptomatic relief and improvement.)

Investigators

Sponsor
Dr Alok Kumar yadav
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials